Regulatory toxicology and pharmacology : RTP
-
Regul. Toxicol. Pharmacol. · Apr 2019
ReviewShort commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products.
A range of generic valsartan products have been found to be contaminated with nitrosamines (principally N-nitrosodimethylamine; NDMA). We present information and discuss various elements of this phenomenon including: actions taken by regulatory agencies, source of the nitrosamine impurities, range of possible risk assessments based mainly on ICH M7 criteria, epidemiological assessment and analytical aspects.